The First-in-Man “Si Se Puede” Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients with limb-threatening ischemia during endovascular therapy

In the European Union, the Lumee™ Oxygen Platform is CE Marked. In the United States, the Lumee Oxygen Platform is an Investigational Device Limited by Federal Law to Investigational Use.

News & Events

For media inquiries, please contact us at media@profusa.com. Follow this link to download the executive summary.

The First-in-Man “Si Se Puede” Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients with limb-threatening ischemia during endovascular therapy

June 2, 2015

The Journal of Vascular Surgery (JVS)